Analysis

Do healthcare cuts risk creating a ‘desert for innovation’ in the UK?

Do healthcare cuts risk creating a ‘desert for innovation’ in the UK?

Pharma Technology Focus – Issue 61

Pharma Technology Focus – Issue 61

Cystic fibrosis: searching for a breakthrough

Cystic fibrosis: searching for a breakthrough

Treating mononucleosis: why the mystery?

Treating mononucleosis: why the mystery?

Reforming paediatric cancer trials in Europe

Reforming paediatric cancer trials in Europe

Immuno-oncology: where to go in a packed field

Immuno-oncology: where to go in a packed field

Sealed with a kisspeptin: the clinical potential of the ‘love hormone’

Sealed with a kisspeptin: the clinical potential of the ‘love hormone’

Pharma Technology Focus – Issue 60

Pharma Technology Focus – Issue 60

Counting the cost of failure in drug development

Counting the cost of failure in drug development

The gene-silencing approach to cutting cholesterol

The gene-silencing approach to cutting cholesterol

Pooling resources for clinical trials

Pooling resources for clinical trials

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Pharma Technology Focus – Issue 59

Pharma Technology Focus – Issue 59

Challenging the link between pharma innovation and US drug pricing

Challenging the link between pharma innovation and US drug pricing

Pharma Technology Focus – Issue 58

Pharma Technology Focus – Issue 58

Cancergraph: a desperately needed link between patient and clinical trial

Cancergraph: a desperately needed link between patient and clinical trial

Pharma Technology Focus – Issue 57

Pharma Technology Focus – Issue 57

Turning to turmeric: exciting drug candidate or another dead end?

Turning to turmeric: exciting drug candidate or another dead end?

Learning from tragedy: safety and dosing in first-in-human trials

Learning from tragedy: safety and dosing in first-in-human trials

Using shark antibodies to treat Alzheimer’s disease

Using shark antibodies to treat Alzheimer’s disease

How an Alzheimer’s drug turned tooth regenerator could unlock regenerative medicine

How an Alzheimer’s drug turned tooth regenerator could unlock regenerative medicine